Cargando…
The Immunological Contribution of a Novel Metabolism-Related Signature to the Prognosis and Anti-Tumor Immunity in Cervical Cancer
SIMPLE SUMMARY: Cervical cancer is the most commonly diagnosed gynecological malignant carcinoma worldwide. It is crucial to develop reliable prognostic models to predict clinical outcomes and identify patients who will benefit from different treatment strategies. In current study, we identified a r...
Autores principales: | Yu, Sihui, Li, Xi, Ma, Mingjun, Yang, Rui, Zhang, Jiawen, Wu, Sufang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139200/ https://www.ncbi.nlm.nih.gov/pubmed/35626004 http://dx.doi.org/10.3390/cancers14102399 |
Ejemplares similares
-
Development of a Novel Immune Infiltration-Based Gene Signature to Predict Prognosis and Immunotherapy Response of Patients With Cervical Cancer
por: Yu, Sihui, et al.
Publicado: (2021) -
High Expression of PAMR1 Predicts Favorable Prognosis and Inhibits Proliferation, Invasion, and Migration in Cervical Cancer
por: Yang, Rui, et al.
Publicado: (2021) -
Emerging role of RNA sensors in tumor microenvironment and immunotherapy
por: Yang, Rui, et al.
Publicado: (2022) -
Dysregulated tumor-associated macrophages in carcinogenesis, progression and targeted therapy of gynecological and breast cancers
por: Xu, Tianhan, et al.
Publicado: (2021) -
Significance of Immunogenic Cell Death-Related Prognostic Gene Signature in Cervical Cancer Prognosis and Anti-Tumor Immunity
por: Jiang, Shan, et al.
Publicado: (2023)